Texte intégral de l'article
 
  Printable version

Vitamin D3 analogues improve café au lait spots in patients with von Recklinghausen’s disease : experimental and clinical studies


European Journal of Dermatology. Volume 9, Number 3, 202-6, April- May 1999, Revues


Summary  

Author(s) : J. Nakayama, H. Kiryu, K. Urabe, S. Matsuo, S. Shibata, T. Koga, M. Furue, Department of Dermatology, Fukuoka University School of Medicine, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan..

Summary : Topical application of vitamin D3 analogues for 6 months was found to be effective in improving the pigmentation of café au lait spots in patients with von Recklinghausen’s disease. Treatment of café au lait spots grafted onto nude mice with a vitamin D3 analogue caused suppression of bromodeoxy- uridine uptake in the cells of the basal layer. Vitamin D3 analogues also decreased melanin pigment in café au lait spots after 4 weeks of treatment. Thus, it is considered that long-term application of vitamin D3 analogues is effective both for improving the pigmentation of café au lait spots and suppressing the development of neurofibromas in patients with von Recklinghausen’s disease.

Keywords : 22-oxacalcitriol, tacalcitol, café au lait spot, neurofibroma, vitamin D3, von Recklinghausen’s disease.

Pictures


   
  

Figure 1. Epidermis containing parts of a café au lait spot was grafted onto nude mice, and 22-oxacalcitriol ointment or white vaseline was topically applied twice a day for 14 days. The grafted skin was resected for H&E staining. A. Control specimen treated with white vaseline. B. Specimen treated with 22-oxacalcitriol ointment. There are many melanophages in the upper dermis showing incontinence of pigment in Figure 1B.




   
  

Figure 2. The same skin specimen shown in Figure 1 except that tissue was immediately frozen for immunostaining with anti-bromodeoxyuridine antibody. Labeling of the epidermis with bromodeoxyuridine was carried out as described in Materials and methods. A. Control specimen treated with white vaseline. B. Specimen treated with 22-oxacalcitriol ointment.




   
  

Figure 3. A large pigmented macule on the back of a patient. Tacalcitol ointment was topically applied twice a day for 6 months. A. Before application. B. After treatment for 6 months.




   
  

Figure 4. A pigmented macule on the upper arm of a patient was topically treated with tacalcitol ointment for 4 weeks and was biopsied to study melanin pigment in the basal layer of the epidermis. A. Before treatment. B. After 4 weeks of treatment. The upper half of the macule was treated with tacalcitol ointment
() and the lower half was treated with white vaseline ().




   
  

Figure 5. Fontana-Masson staining of the epidermis of the pigmented macule shown in Figure 4. A. The upper half of the pigmented macule treated with tacalcitol ointment. B. The lower half of the pigmented macule treated with white vaseline.